Results 211 to 220 of about 67,047,750 (228)

Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

New England Journal of Medicine, 2023
Eduardo Perna, Julio Núñez
exaly  

Heart Failure With Preserved Ejection Fraction: A Review

JAMA - Journal of the American Medical Association, 2023
Barry A Borlaug
exaly  

Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction

European Heart Journal, 2022
Faiez Zannad, Javed Butler, Cordula Zeller   +2 more
exaly  

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

New England Journal of Medicine, 2020
Kevin J Anstrom, Javed Butler, Paul W Armstrong   +2 more
exaly  

Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes.

Journal of the American College of Cardiology, 2017
Roland A. Matsouaka
exaly  

Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction: The Aldo-DHF Randomized Controlled Trial

JAMA - Journal of the American Medical Association, 2013
Carsten Tschöpe, Christoph Herrmann-Lingen, Rolf Wachter   +2 more
exaly  

Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial

JAMA - Journal of the American Medical Association, 2013
Barry A Borlaug, Russell P Tracy, Horng H Chen   +2 more
exaly  

Spironolactone for Heart Failure with Preserved Ejection Fraction

New England Journal of Medicine, 2014
Bertram Pitt, Song Yang, Brian Claggett
exaly  

Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection Fraction

Journal of the American College of Cardiology, 2014
Bertram Pitt, Faiez Zannad, Martin Cowie
exaly  

Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction

New England Journal of Medicine, 2008
Michael R Zile, Robert S McKelvie
exaly